ab
antibodi
ag
antigen
alt
aminotransferas
ast
aminotransferas
cft
complement
fixat
test
eia
enzymelink
immunosorb
assay
ggt
gammaglutamyl
transferas
ifa
indirect
fluoresc
antibodi
igm
immunoglobulin
wbc
white
blood
cell
count
object
immunodefici
patient
particularli
vulner
neuroinvas
infect
challeng
diagnos
metagenom
next
gener
sequenc
identifi
unusu
novel
microb
therefor
well
suit
investig
etiolog
chronic
meningoenceph
immunodefici
patient
method
present
case
man
xlink
agammaglobulinemia
australia
suffer
year
meningoenceph
defi
etiolog
diagnosi
despit
extens
convent
test
includ
brain
biopsi
metagenom
next
gener
sequenc
cerebrospin
fluid
brain
biopsi
tissu
perform
identifi
caus
pathogen
result
sequenc
align
multipl
cach
valley
viru
gene
identifi
via
metagenom
next
gener
sequenc
revers
transcript
polymeras
chain
reaction
immunohistochemistri
subsequ
confirm
presenc
cach
valley
viru
brain
biopsi
tissu
interpret
cach
valley
viru
mosquitoborn
orthobunyaviru
identifi
immunocompet
north
american
patient
acut
neuroinvas
diseas
report
sever
rang
selflimit
mening
rapidli
fatal
meningoenceph
multiorgan
failur
viru
never
known
caus
chronic
system
neurolog
infect
human
cach
valley
viru
also
never
previous
detect
australian
contin
research
subject
travel
north
south
carolina
michigan
week
prior
onset
ill
report
demonstr
metagenom
next
gener
sequenc
allow
unbias
pathogen
identif
earli
detect
emerg
virus
spread
new
local
discoveri
novel
diseas
phenotyp
ann
neurol
utbreak
emerg
reemerg
pathogen
stimul
intern
discuss
effici
mean
improv
earli
detect
public
privat
resourc
mobil
quickli
effici
limit
widespread
transmiss
treat
affect
patient
grow
consensu
optim
surveil
regimen
incorpor
unbias
approach
pathogen
identif
focu
surveil
effort
group
peopl
high
risk
unusu
infect
eg
immunodefici
patient
peopl
relev
exposur
unbias
approach
pathogen
identif
import
tradit
candidatebas
diagnost
test
essenti
fail
identifi
novel
unusu
pathogen
usual
due
perceiv
rariti
exclus
clinic
consider
base
establish
geograph
distribut
global
surveil
effort
need
streamlin
timeconsum
costli
physician
order
mani
pathogenspecif
test
geograph
clinic
novel
organ
final
modern
era
intern
travel
becom
commonplac
need
improv
pathogen
detect
becom
clear
report
effect
deploy
metagenom
next
gener
sequenc
mng
diagnos
cach
valley
viru
cvv
mosquitoborn
orthobunyaviru
australian
patient
primari
immunodefici
suffer
chronic
meningoenceph
case
demonstr
power
mng
identifi
possibl
movement
emerg
mosquitoborn
viru
new
contin
previous
associ
acut
neuroinvas
diseas
report
also
extend
phenotyp
cvv
infect
human
patient
method
patient
man
australia
histori
hypochondroplasia
xlink
agammaglobulinemia
confirm
germlin
mutat
fibroblast
growth
factor
receptor
bruton
tyrosin
kinas
btk
respect
antibodi
defici
diagnos
infanc
patient
commenc
lifelong
intraven
immunoglobulin
ivig
therapi
patient
suffer
chronic
sinus
despit
ivig
therapi
treat
clarithromycin
prophylaxi
despit
mild
development
delay
associ
learn
difficulti
complet
school
vocat
train
went
fulltim
employ
retail
store
manag
patient
travel
unit
state
occas
first
trip
raleigh
north
carolina
spring
second
visit
summer
month
later
start
raleigh
also
includ
trip
charleston
south
carolina
patient
particip
tube
along
local
river
nearli
monthlong
trip
patient
complain
mosquito
bite
travel
companion
two
week
later
travel
east
lans
michigan
upon
return
home
australia
week
later
patient
fell
ill
within
day
parent
report
fatigu
anorexia
lethargi
six
day
later
patient
suffer
acut
encephalit
ill
character
fever
confus
postict
drowsi
follow
gener
tonicclon
seizur
patient
intub
transfer
intens
care
unit
blood
test
reveal
lymphocytosi
l
normal
rang
nr
l
creactiv
protein
level
nr
cerebrospin
fluid
csf
studi
reveal
normal
concentr
protein
mgdl
glucos
mgdl
l
white
blood
cell
neutrophil
lymphocyt
monocyt
l
red
blood
cell
magnet
reson
imag
mri
brain
reveal
increas
signal
restrict
diffus
right
fornix
extend
right
hippocampu
amygdala
fig
b
interv
develop
contrast
enhanc
brain
structur
week
later
fig
microbiolog
test
includ
cultur
polymeras
chain
reaction
pcr
candid
pathogen
fail
identifi
organ
tabl
patient
treat
empir
acyclovir
ceftriaxon
benzylpenicillin
vancomycin
vancomycin
benzylpenicillin
discontinu
due
develop
rash
patient
hip
azithromycin
start
due
leftsid
consolid
observ
chest
xray
patient
complet
day
antimicrobi
therapi
clinic
improv
seizur
disord
control
levetiracetam
sodium
valproat
discharg
hospit
readmit
day
later
hypersomnol
fluctuat
level
conscious
antiepilept
medic
adjust
discharg
home
patient
made
partial
recoveri
next
month
new
shortterm
memori
loss
ultim
abl
return
work
reduc
capac
next
year
patient
remain
seizur
free
util
compensatori
cope
strategi
work
due
signific
shortterm
memori
deficit
otherwis
independ
activ
daili
live
home
parent
report
anxieti
fatigu
specif
diagnos
made
spring
patient
present
reevalu
parent
report
month
progress
memori
declin
slow
speech
mood
disturb
predominantli
anxieti
intermitt
tremor
longer
abl
work
due
encephalopathi
need
assist
activ
daili
live
neurolog
examin
reveal
languag
fluent
monoton
montreal
cognit
assess
score
sever
impair
visuospati
execut
function
attent
abstract
delay
recal
could
perform
luria
maneuv
unabl
mimic
simpl
hand
gestur
fine
jerki
postur
tremor
arm
outstretch
diffus
muscl
rigid
beat
ankl
clonu
bilater
could
stand
independ
broadbas
gait
reduc
stride
length
stoop
postur
en
bloc
turn
followup
brain
mri
demonstr
interv
develop
diffus
cerebr
atrophi
ex
vacuo
hydrocephalu
addit
focal
atrophi
right
medial
tempor
lobe
fig
mri
spinal
cord
unremark
repeat
csf
examin
unremark
tabl
show
normal
open
pressur
normal
pressur
hydrocephalu
exclud
larg
volum
csf
extract
ml
compar
neuropsycholog
test
brain
biopsi
right
frontal
lobe
reveal
featur
meningoenceph
inflam
fibrou
leptomening
scatter
microgli
nodul
perivascular
well
interstiti
lymphocyt
infiltr
cortex
fig
white
matter
also
contain
microgli
nodul
small
number
perivascular
lymphocyt
shown
perivascular
interstiti
lymphocyt
infiltr
compos
predominantli
lymphocyt
viral
cytopath
chang
seen
convent
csf
brain
biopsi
studi
fail
identifi
caus
organ
tabl
sampl
csf
piec
surplu
brain
biopsi
tissu
collect
rnasednasefre
lobind
tube
sigmaaldrich
st
loui
mo
snap
frozen
liquid
nitrogen
sampl
submit
unbias
mng
research
protocol
identif
potenti
pathogen
approv
institut
review
board
univers
california
san
francisco
ucsf
common
issu
metagenom
sequenc
essenti
reagent
use
librari
prepar
process
contain
extran
nucleic
acid
includ
materi
commonli
present
laboratori
reagent
process
acquir
human
sampl
also
introduc
unwant
nucleic
acid
skin
environment
contamin
control
irrelev
sequenc
unrel
uninfect
human
csf
sampl
control
prepar
parallel
sequenc
run
addit
water
control
sampl
process
figur
neuroimag
acut
present
coron
invers
recoveri
brain
magnet
reson
imag
mri
demonstr
hyperintens
right
hippocampu
amygdala
arrow
b
axial
diffusionweight
imag
brain
mri
demonstr
restrict
diffus
right
hippocampu
amygdala
arrow
c
sagitt
c
coron
postcontrast
brain
mri
demonstr
contrast
enhanc
week
acut
present
arrow
mng
analysi
previous
describ
complementari
dna
cdna
cdna
convert
illumina
san
diego
ca
librari
use
nebnext
ultra
ii
dna
librari
prepar
kit
accord
manufactur
recommend
amplifi
pcr
cycl
librari
subject
addit
step
select
deplet
librari
amplicon
whose
sequenc
correspond
human
mitochondri
genom
accomplish
via
deplet
abund
sequenc
hybrid
dash
novel
molecular
techniqu
use
crispr
cluster
regularli
interspac
short
palindrom
repeat
associ
nucleas
vitro
pool
librari
sizeselect
use
ampur
bead
concentr
determin
use
kapa
univers
quantit
pcr
kit
kapa
biosystem
woburn
sampl
sequenc
illumina
hiseq
instrument
use
base
pair
pairedend
sequenc
sequenc
analyz
use
rapid
comput
pipelin
develop
derisi
laboratori
classifi
mng
read
identifi
potenti
pathogen
comparison
entir
nation
center
biotechnolog
inform
ncbi
nucleotid
nt
refer
databas
previous
describ
detail
briefli
pairedend
read
align
human
refer
genom
pan
troglodyt
genom
univers
california
santa
cruz
unalign
ie
nonhuman
read
qualiti
filter
use
priceseqfilt
qualiti
filter
read
compress
cdhitdup
lowcomplex
read
remov
via
lempelzivwelch
algorithm
next
human
remov
repeat
use
refer
genom
describ
gsnapl
use
align
remain
nonhuman
read
pair
ncbi
nt
databas
preprocess
remov
known
repetit
sequenc
repeatmask
wwwrepeatmaskerorg
read
also
align
ncbi
nonredund
protein
nr
databas
use
algorithm
result
sequenc
hit
identifi
nt
total
pairedend
read
obtain
csf
brain
biopsi
specimen
respect
describ
pairedend
sequenc
process
custom
bioinformat
pipelin
runtim
bioinformat
pipelin
describ
minut
per
sampl
singl
server
filter
genera
remain
mng
dataset
csf
sampl
bunyamwera
viru
taxid
cucumb
green
mottl
mosaic
viru
taxid
bunyamwera
viru
consid
credibl
pathogen
speci
level
uniqu
pair
bunyamwera
viru
read
map
cvv
nucleoprotein
rnadepend
rna
polymeras
similar
although
bunyamwera
viru
sequenc
identifi
nt
result
brain
biopsi
sampl
nr
output
identifi
uniqu
read
pair
map
similar
cvv
small
genom
segment
encod
nucleocapsid
protein
nonstructur
protein
thu
simpl
conserv
algorithm
describ
result
singl
taxonom
categori
cvv
patient
csf
sampl
upon
investig
also
present
brain
biopsi
sampl
cvv
orthobunyaviru
known
caus
acut
neuroinvas
diseas
chronic
meningoenceph
cvv
sequenc
never
previous
detect
laboratori
cvv
reagent
materi
present
laboratori
nonhuman
sequenc
read
correspond
librari
patient
deposit
ncbi
sequenc
read
archiv
bioproject
revers
transcriptionpcr
rtpcr
perform
patient
brain
biopsi
tissu
csf
use
previous
publish
cvv
primer
polyprotein
gene
ie
cvv
forward
ccaatgcaattcagggcagt
revers
tgagtcaccacatgctgtaaggt
accord
slightli
modifi
version
publish
protocol
rtpcr
unsuccess
csf
amplicon
brain
biopsi
tissu
rna
clone
one
shot
chemic
compet
escherichia
coli
use
topota
clone
kit
accord
manufactur
protocol
thermo
fisher
scientif
waltham
ampicillinresist
coloni
sanger
sequenc
quintara
bioscienc
south
san
francisco
ca
clone
sequenc
unambigu
align
cvv
similar
basic
local
align
search
tool
search
ncbi
also
return
cvv
hit
align
virus
rnadepend
rna
polymeras
sequenc
close
relat
australian
orthobunyaviru
kowanyama
viru
genbank
similar
viral
polymeras
sequenc
obtain
subject
sampl
viru
cultur
fresh
csf
attempt
multipl
cell
line
vero
vero
aed
albopictu
buffalo
green
monkey
kidney
human
fetal
lung
rhabdomyosarcoma
rd
without
success
immunohistochemistri
perform
lm
section
formalinfix
paraffinembed
tissu
follow
previous
describ
method
minor
modif
includ
rabbit
polyclon
antibodi
cvv
dilut
normal
rabbit
igg
incub
hour
serumfre
protein
block
incub
dako
carpinteria
ca
polymerbas
secondari
antibodi
incub
thermo
fisher
scientif
fremont
ca
ovin
fetal
central
nervou
system
cn
tissu
skelet
muscl
experiment
infect
cvv
noninfect
human
brain
tissu
includ
posit
neg
control
respect
experiment
infect
ovin
fetu
demonstr
strong
intracytoplasm
immunostain
immunostain
observ
noninfect
human
neg
control
brain
tissu
subject
brain
show
intracytoplasm
immunostain
primarili
seen
within
glial
cell
form
glial
nodul
brain
parenchyma
fig
although
virus
typic
associ
acut
present
meningoenceph
known
caus
chronic
cn
infect
immunocompet
patient
known
suffer
chronic
cn
infect
caus
paramyxovirus
measl
viru
nipah
viru
herp
virus
varicella
zoster
viru
wherea
immunodefici
patient
suffer
chronic
neurolog
infect
human
immunodefici
viru
type
epsteinbarr
viru
enterovirus
polyomavirus
astrovirus
coronaviru
even
mump
viru
report
expand
spectrum
viral
caus
chronic
meningoenceph
set
immunodefici
includ
orthobunyaviru
cvv
mosquitoborn
orthobunyaviru
first
identifi
cach
valley
utah
orthobunyavirus
segment
negativestrand
rna
virus
whose
genom
compos
larg
medium
small
segment
virus
orthobunyaviru
famili
public
health
import
includ
california
enceph
viru
jamestown
canyon
viru
lacross
viru
cvv
volum
rare
report
caus
neuroinvas
diseas
immunocompet
patient
clinic
present
rang
selflimit
asept
mening
fatal
meningoenceph
multiorgan
failur
cvv
previous
report
caus
chronic
infect
human
although
approv
antivir
agent
known
treat
cvv
identif
viru
reinforc
switch
obtain
ivig
pool
australian
donor
ivig
pool
donor
unit
state
given
possibl
latter
ivig
donor
pool
might
contain
neutral
antibodi
cvv
unfortun
chang
treatment
strategi
arrest
patient
relentless
neurolog
declin
ataxia
progress
could
longer
walk
ceas
commun
verbal
eventu
stop
eat
drift
coma
place
hospic
care
die
earli
month
initi
present
death
parent
report
deriv
great
comfort
know
underli
caus
son
ill
patient
case
highlight
need
make
specif
microbiolog
diagnos
target
therapi
develop
also
provid
clariti
patient
famili
wherea
cvv
widespread
throughout
north
south
america
member
bunyamwera
serogroup
previous
detect
australia
given
cvv
mosquitoborn
viru
carri
least
speci
mosquito
across
genera
like
mosquito
speci
compet
transmit
cvv
australia
although
evid
wider
transmiss
occur
plausibl
subject
could
transmit
cvv
mosquito
australia
period
sinc
return
unit
state
possibl
introduc
mosquitoborn
viru
new
local
made
even
salient
recent
intern
zika
viru
crisi
spread
zika
latin
america
part
exacerb
delay
recognit
introduct
brazil
recent
phylogenet
studi
indic
zika
viru
circul
month
identifi
pathogen
month
determin
zika
like
respons
recent
increas
incid
microcephali
dramat
exampl
viru
spread
undetect
among
human
popul
mani
decad
remain
cvv
rare
identifi
caus
human
diseas
report
australia
previous
tradit
candidatebas
diagnost
test
viru
avail
australia
unusu
case
highlight
abil
mng
identifi
pathogen
previous
associ
clinic
phenotyp
known
circul
geograph
area
also
import
note
mng
abl
identifi
cvv
csf
patient
result
avail
brain
biopsi
could
obviat
need
invas
procedur
abil
identifi
unanticip
infect
csf
via
mng
patient
other
motiv
ongo
prospect
multicent
studi
current
underway
determin
perform
characterist
mng
csf
assay
perform
clinic
laboratori
environ
patient
acut
mening
without
enceph
http
www
ciapmorgprojectprecisiondiagnosisacuteinfectiousdiseas
appli
broadli
global
pathogen
surveil
effort
mng
significantli
enhanc
detect
monitor
global
biothreat
final
case
extend
spectrum
virus
known
caus
chronic
meningoenceph
